Skip to main content
. 2011 Mar 15;3(1):1329–1350. doi: 10.3390/cancers3011329

Figure 1.

Figure 1.

Acute myeloid leukemia (AML) cell lines show varied resistance to rhTRAIL. AML cell lines were treated with 10, 50, 250 or 1000 ng/mL TRAIL for 24 h. Cell viability was measured by MTT assay; values are expressed as a percent of untreated cells and presented as mean ± S.E.M.